A Study to Investigate Efficacy and Safety of VTAMA® (Tapinarof) Cream, 1% in Plaque Psoriasis in the Head and Neck Region
Public ClinicalTrials.gov record NCT05789576. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 4, Open-label Study to Investigate the Efficacy and Safety of VTAMA® (Tapinarof) Cream, 1% in the Treatment of Plaque Psoriasis Occurring in the Head and Neck Region
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is an open-label, multi-center study to evaluate the efficacy and safety of VTAMA (tapinarof) cream, 1% in adults with plaque psoriasis occurring in the head and neck region
Study identification
- NCT ID
- NCT05789576
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 31 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 13, 2023 (Actual)
- Primary completion
- Jun 30, 2023 (Actual)
- Completion
- Jul 19, 2023 (Actual)
- Last update posted
- Jun 12, 2025
2023
United States locations
- U.S. sites
- 10
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Dermavant Investigative Site | Macon | Georgia | 31217 | — |
| Dermavant Investigative Site | Chicago | Illinois | 60602 | — |
| Dermavant Investigative Sites | Rockville | Maryland | 20850 | — |
| Dermavant Investigative Site | Auburn Hills | Michigan | 48326 | — |
| Dermavant Investigative Site | Detroit | Michigan | 48202 | — |
| Dermavant Investigative Site | Las Vegas | Nevada | 89144 | — |
| Dermavant Investigative Site | Portsmouth | New Hampshire | 03801 | — |
| Dermavant Investigative Site | Kew Gardens | New York | 11415 | — |
| Dermavant Investigative Site | Marion | Ohio | 43302 | — |
| Dermavant Investigative Site | Arlington | Texas | 76014 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05789576, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 12, 2025 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05789576 live on ClinicalTrials.gov.